Discovery of Cytotoxic Barbiturate-Bridged Dimeric Chrolactomycins from TX15.

Org Lett

Helmholtz International Lab for Anti-infectives, Shandong University-Helmholtz Institute of Biotechnology, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, Shandong 266237, China.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Six new spirotetronate polyketides, chrolactomycins A-F (-), and the known chrolactomycin () were isolated and identified from TX15. Chrolactomycins D-F (-) feature an unprecedented dimeric skeleton bridged by a rare barbiturate unit. Sequencing and characterization of a type I polyketide synthase biosynthetic gene cluster led to the proposal of a biosynthetic pathway for -. Compounds - exhibited antibacterial activities, while - displayed cytotoxicity to multiple cancer cell lines, with dimer demonstrating the most potent effects (IC = 2.2-7.7 μM).

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.orglett.5c02941DOI Listing

Publication Analysis

Top Keywords

discovery cytotoxic
4
cytotoxic barbiturate-bridged
4
barbiturate-bridged dimeric
4
dimeric chrolactomycins
4
chrolactomycins tx15
4
tx15 spirotetronate
4
spirotetronate polyketides
4
polyketides chrolactomycins
4
chrolactomycins a-f
4
a-f chrolactomycin
4

Similar Publications

Leishmaniasis, a disease caused by Leishmania parasites, poses a significant health threat globally, particularly in Latin America and Brazil. Leishmania amazonensis is an important species because it is associated with both cutaneous leishmaniasis and an atypical visceral form. Current treatments are hindered by toxicity, resistance, and high cost, driving the need for new therapeutic targets and drugs.

View Article and Find Full Text PDF

Among the most pervasive malignancies affecting females worldwide, breast cancer is responsible for approximately 2.2 million new diagnoses and over 660,000 fatalities reported annually. Natural products represent an invaluable resource for the identification and development of potential innovative anti-cancer pharmaceuticals.

View Article and Find Full Text PDF

Discovery of C-3 nitrothiophene substituted thiochromone derivatives as potent and selective human monoamine oxidase B (hMAO-B) inhibitors for the treatment of atherosclerosis.

Bioorg Chem

August 2025

Key Lab of Protein Structure and Function of Universities in Hunan Province, University of South China, Hengyang, Hunan 421001, China; School of Chemistry and Chemical Engineering, University of South China, Hengyang, Hunan 421001, China. Electronic address:

Inhibition of human monoamine oxidase B (hMAO-B) to prevent both oxidative stress and lipid metabolism disorders, which are high-risk factors for pathogenesis of atherosclerosis, is a potential strategy for the treatment of atherosclerosis. In this study, we have explored a series of C-3 nitrothiophene substituted thiochromone analogues that showed good to excellent potency against hMAO-B. The strategy of introduction the nitro-group into thiophene linker, which contributes pivotal interactions with Cys172, significantly improved the potency and selectivity of these compounds.

View Article and Find Full Text PDF

A machine learning-based analysis method for small molecule high content screening of three-dimensional cancer spheroid morphology.

Mol Pharmacol

August 2025

Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland. Electronic address:

Although multiparameter cellular morphological profiling methods and three-dimensional (3D) biological model systems can potentially provide complex insights for pharmaceutical discovery campaigns, there have been relatively few reports combining these experimental approaches. In this study, we used the U87 glioblastoma cell line grown in a 3D spheroid format to validate a multiparameter cellular morphological profiling screening method. The steps of this approach include 3D spheroid treatment, cell staining, fully automated digital image acquisition, image segmentation, numerical feature extraction, and multiple machine learning approaches for cellular profiling.

View Article and Find Full Text PDF

Discovery of novel xanthotoxin-pyridine quaternary ammonium derivatives with membrane-targeting mode of action as potential antimicrobials against methicillin-resistant Staphylococcus aureus.

Eur J Med Chem

September 2025

Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan Province, China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan Province,

Methicillin-resistant Staphylococcus aureus (MRSA) is a major global health threat owing to its multi-drug resistance, creating an urgent need for novel antibiotics. This study focused on developing anti-MRSA agents by designing and synthesizing 30 xanthotoxin-pyridine quaternary ammonium derivatives, followed by evaluating their antibacterial activity and dissecting their mechanism of action against MRSA. Among all derivatives, III13 demonstrated as the most promising candidate: it exhibited potent anti-MRSA activity (MIC = 1 μg/mL), low cytotoxicity, minimal hemolysis, rapid bactericidal effects, and the ability to disrupt biofilms.

View Article and Find Full Text PDF